ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group
Annals of Hematology
◽
10.1007/s002770050148
◽
1996
◽
Vol 72
(3)
◽
pp. 119-124
◽
Cited By ~ 12
Author(s):
T. De Witte
◽
S. Suciu
◽
D. Selleslag
◽
B. Labar
◽
K. Roozendaal
◽
...
Keyword(s):
Phase Ii
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Salvage Treatment
◽
Myelogenous Leukemia
◽
Cooperative Group
◽
Acute Myelogenous
◽
Intermediate Dose
Download Full-text
Related Documents
Cited By
References
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Haematologica
◽
10.3324/haematol.2012.062539
◽
2012
◽
Vol 97
(11)
◽
pp. 1736-1742
◽
Cited By ~ 41
Author(s):
J. E. Karp
◽
E. Garrett-Mayer
◽
E. H. Estey
◽
M. A. Rudek
◽
B. D. Smith
◽
...
Keyword(s):
Phase Ii
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Sequential Therapy
◽
Myelogenous Leukemia
◽
Newly Diagnosed
◽
Poor Risk
◽
Randomized Phase Ii
◽
Acute Myelogenous
Download Full-text
Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide
Leukemia Research
◽
10.1016/s0145-2126(02)00177-7
◽
2003
◽
Vol 27
(4)
◽
pp. 313-321
◽
Cited By ~ 27
Author(s):
Javier Bolaños-Meade
◽
Judith E Karp
◽
Chuanfa Guo
◽
Clarence B Sarkodee-Adoo
◽
Aaron P Rapoport
◽
...
Keyword(s):
Phase Ii
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Sequential Therapy
◽
Myelogenous Leukemia
◽
Sequential Administration
◽
Acute Myelogenous
Download Full-text
A Phase II Study of Sequential Decitabine and Rapamycin in Acute Myelogenous Leukemia
Leukemia Research
◽
10.1016/j.leukres.2021.106749
◽
2021
◽
pp. 106749
Author(s):
Jane L. Liesveld
◽
Andrea Baran
◽
Mitra Azadniv
◽
Haley Misch
◽
Katherine Nedrow
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2019.10.018
◽
2020
◽
Vol 20
(4)
◽
pp. 226-233.e1
Author(s):
Benjamin K. Tomlinson
◽
Molly M. Gallogly
◽
Donna M. Kane
◽
Leland Metheny
◽
Hillard M. Lazarus
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Wild Type
◽
Acute Myelogenous
◽
Unfit Patients
Download Full-text
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia
Cancer
◽
10.1002/1097-0142(19890301)63:5<813::aid-cncr2820630502>3.0.co;2-v
◽
1989
◽
Vol 63
(5)
◽
pp. 813-817
◽
Cited By ~ 36
Author(s):
Hagop M. Kantarjian
◽
Michael J. Keating
◽
Ronald S. Walters
◽
Charles A. Koller
◽
Kenneth B. McCredie
◽
...
Keyword(s):
Continuous Infusion
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Low Dose
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
A Phase II study of VNP40101M in elderly patients (pts) with de novo poor risk acute myelogenous leukemia (AML)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.7026
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 7026-7026
◽
Cited By ~ 2
Author(s):
G. J. Schiller
◽
D. DeAngelo
◽
N. Vey
◽
S. Solomon
◽
R. Stuart
◽
...
Keyword(s):
Elderly Patients
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
De Novo
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Poor Risk
◽
Acute Myelogenous
Download Full-text
Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.6541
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 6541-6541
◽
Cited By ~ 3
Author(s):
F. J. Giles
◽
S. O’Brien
◽
N. Vey
◽
E. Feldman
◽
D. Rizzieri
◽
...
Keyword(s):
High Risk
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Phase II study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.7025
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 7025-7025
◽
Cited By ~ 5
Author(s):
H. P. Erba
◽
H. M. Kantarjian
◽
D. Claxton
◽
M. Arellano
◽
R. Lyons
◽
...
Keyword(s):
Older Adult
◽
Induction Chemotherapy
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Single Agent
◽
Adult Patients
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Intermediate-Dose Cytosine Arabinoside and Amsacrine for Remission Induction and High-Dose Cytosine Arabinoside and Amsacrine for Intensive Consolidation in Relapsed and Refractory Adult Acute Myelogenous Leukemia
Leukemias
◽
10.1007/978-3-642-77083-8_43
◽
1993
◽
pp. 233-240
◽
Cited By ~ 1
Author(s):
U. Jehn
◽
V. Heinemann
Keyword(s):
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Myelogenous Leukemia
◽
Remission Induction
◽
High Dose
◽
Acute Myelogenous
◽
Intermediate Dose
Download Full-text
Intensive Induction Therapy with Behenoyl, Cytosine Arabinoside, Daunorubicin, and 6-Mercaptopurine Followed by Intensive Consolidation with Mitoxantrone, Etoposide, Vincristine, and Intermediate-Dose Continuous Cytarabine (M-85 Protocol) for Adult Acute Myelogenous Leukemia
Acute Leukemias II - Haematology and Blood Transfusion / Hämatologie und Bluttransfusion
◽
10.1007/978-3-642-74643-7_55
◽
1990
◽
pp. 304-308
Author(s):
R. Ohno
◽
S. Yokomaku
◽
M. Okumara
◽
M. Tanimoto
◽
Y. Morishita
◽
...
Keyword(s):
Induction Therapy
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Myelogenous Leukemia
◽
Acute Myelogenous
◽
Intermediate Dose
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close